Anemia in Vascular Complications Development Associated with Diabetes Mellitus: Is It a Reason or Consequence?

Main Article Content

Yu.V. Korzun
L.K. Sokolova


The patients with cardiorenal anemic syndrome are considered to be the most serious ones with a high cardiorenal risk related to mutual negative impact of severe pathological conditions. The presence of cardiorenal anemic syndrome in diabetic patients exacerbates the forecast for life quality and requires personal approach to the treatment.

Article Details

How to Cite
Korzun, Y., and L. Sokolova. “Anemia in Vascular Complications Development Associated With Diabetes Mellitus: Is It a Reason or Consequence?”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 6.62, Oct. 2014, pp. 66-70, doi:10.22141/2224-0721.6.62.2014.76939.
To practicing Endocrinologists


Dunlay S.M., Weston S.A., Redfield M.M. et al. Anemia and heart failure: A communite study // Am. J. Med. — 2008. — 121. — 726-732.

Groenveld H.F., Januzzi J.L., Damman K. et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis // J. Am. Coll. Cardiol. — 2008. — 52. — 818-827.

Groop P.H., Thomas M.C., Moran J.L. et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type I Diabetes // Diabetes. — 2009. — 58(7). — 1651-1658.

World Health Organization: Nutritional anaemias: report of a WHO Scientific Group. — Geneva, Switzerland: World Health Organization, 1968.

Locatelli F., Aljama P., Barany P. et al. Revised European best practice guidelines for the management of anemia in patients with chronic renal failure // Nephrol. Dial. Transplant. — 2004. — 19(2). — іі1-іі47.

Ishani A., Weinhandl E., Zhao Z. et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia; and the impact of incident anemia on mortality in patients with left ventricular dysfunction // J. Am. Coll. Cardiol. — 2005. — 45. — P. 391-9.

Irace C., Scarinici F., Scorcia et al. Association among low whole blood viscosity, haemotocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes // Br. J. Ophthalmol. bjo.2009.172601. — Published Online First: 8 June 2010. doi:10.1136/bjo.2009.172601.

Sonmez A., Yilmaz M.I., Saglam M. et al. The Relationship between Hemoglobin Levels and Endotelial Functions in Diabetes Mellitus // J. Am. Society of Nephrology. — 2010. — 5. — 45-50.

McGill J.B., Bell D.S. Anemia and the role of erythropoietin in diabetes // J. Diabetes Complications. — 2006. — 20(4). — 262-72.

Thomas S., Rampersad M. Anemia in diabetes // Acta Diabetol. — 2004. — 41 (suppl. 1). — S13-S17.

Conway B.N., Miller R.G., Orchard T.J. Are Hemoglobin Levels Elevated in Type 1 Diabetes? // Diabetes Care. — 2010. — 33(2). — 341-343.

Locatelli F., Becker H. Update on Anemia management in Nephrology, Including Current Guidelines on the Use of Erythropoiesis-Stimulating Agents and Implications of the Introductions of «Biosimilars» // Onkologist. — 2009. — 14 (suppl. 1). — 16-21.

Van der Meer P., Voors A.A., Lipsic E. et al. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure // J. Am. Coll. Cardiol. — 2004. — 44. — P. 63-7.

Volpe M., Tritto C., Testa U. et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles // Am. J. Cardiol. — 1994. — 74. — P. 483-73.

Bolger A.P., Barlett F.R., Pension H.S. et al. Intravenous iron alone the treatment of anemia in patients with chronic heart failure // J. A. Coll. Cardiol. — 2006. — 48. — P. 1225-7.

Ghali J.K., Anand I.S., Abraham W.T. et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia // Circulation. — 2008. — 117. — P. 783-788.

Go A.S., Yang J., Lynn M. et al. Hemoglobin level, chronic kidney disease and the risks of death and hospitalization in adults with chronic heart failure // Circulation. — 2006. — 113. — P. 2713-2723.

Astor B.C., Muntner P., Levin A. et al. Association of kidney function with anemia // Arch. Inter. Med. — 2002. — 162. — P. 1401-1408.

Lorber D., Reddan D. Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study // Clin. Nephrol. — 2006. — 66. — P. 11-16.

Thomas M.S., Mac Isaac R.J., Tsalamandris C. et al. Unrecognized anemia in patients with diabetes: a cross-sectional survey // Diabetes Care. — 2003. — 26. — P. 1164-1169.

Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure // Circulation. — 2003. — 107. — P. 223-6.

Carson J.L. Morbidity risk assessment in the surgically anemic patients // Av. J. Surg. — 1995. — 170 Suppl. — P. 32-3.

Rigatto C., Parfrey P., Foley R. et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease //Am. Sac. Nephro. — 2002. — 13. — P. 1084-1090.

Most read articles by the same author(s)

1 2 > >>